As pharmaceutical and life sciences companies work to accelerate development processes, digital technologies offer a path to greater efficiency, adaptability and speed. The Digital Twin and Industrial AI are expected to become particularly impactful.

In this episode of the Future Ready Podcast from Siemens, listen to experts on the pharmaceutical and life sciences industry dive into how digital transformation speeds development, the modeling of molecules with the Digital Twin and how AI is already influencing drug discovery.

In this episode you’ll learn about: 

(00:00) Introduction

(01:02) Digitalization in drug development

(06:38) Using the Digital Twin in tech transfers

(09:46) The Digital Twin from molecule to market

(17:02) Scaling Industrial AI across the lifecycle

About the voices: 

Maria Grahm is the Global VP of Life Sciences for Siemens. Maria is responsible for managing how Siemens applies its full portfolio, including smart infrastructure, digital industries, and software, to lead digital transformation from molecule to market.

Andy Whytock is the Head of Market Strategy and Thought Leadership of Life Sciences at Siemens. Andy is responsible for driving digital transformation initiatives and thought leadership activities in the pharmaceutical and life sciences sector and specializes in helping life sciences manufacturers embrace digital transformation, adopt cutting-edge technologies and evolve into fully connected, data-driven and sustainable enterprises.

Conor Peick is a Marketing Professional creating forward-looking content for the Thought Leadership team at Siemens Digital Industries Software. Conor collaborates with industry experts and executives to produce impactful content exploring the challenges companies face and the technologies that can provide solutions.